Related Experiment Video
Updated: May 1, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
15.6K
Method for analysis of nanoparticle hemolytic properties in vitro
Barry W Neun1, Marina A Dobrovolskaia
1Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD, USA.
Methods in Molecular Biology (Clifton, N.J.)
|December 1, 2010
Summary
This study introduces a new in vitro assay to measure how nanoparticles damage red blood cells (RBCs). The assay quantifies nanoparticle-induced hemolysis by measuring released hemoglobin, aiding nanoparticle safety assessments.
Area of Science:
- Biomedical Engineering
- Nanotoxicology
- Hematology
Background:
- Hemolysis, the damage to red blood cells (RBCs), releases hemoglobin into plasma.
- Assessing nanoparticle-induced hemolysis is crucial for evaluating nanomaterial safety.
- Existing methods may not fully capture the complexities of nanoparticle-RBC interactions.
Purpose of the Study:
- To develop and validate a novel in vitro assay for quantifying nanoparticle hemolytic properties.
- To provide a reliable method for assessing the potential of nanoparticles to cause red blood cell damage.
Main Methods:
- Incubation of nanoparticles with whole blood.
- Quantification of released hemoglobin via spectrophotometry after conversion to cyanmethemoglobin.
- Comparison to a negative control to determine percentage of hemolysis.
Main Results:
- The assay accurately measures hemoglobin release indicative of RBC damage.
- Spectrophotometric analysis provides a quantitative measure of nanoparticle-induced hemolysis.
- The method allows for the determination of the percentage of hemolysis caused by specific nanoparticles.
Conclusions:
- The described in vitro assay is a robust tool for evaluating nanoparticle hemolytic activity.
- This assay facilitates the safety assessment of nanoparticles by quantifying their impact on red blood cells.
- The developed method offers a standardized approach to assess nanoparticle-induced hemolysis.
